comparemela.com
Home
Live Updates
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024 : comparemela.com
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
Results showed single-administration GLP-1 pancreatic gene therapy candidate reduced liver weight by 42% and liver triglycerides by 67% compared to placebo two months after administration Data also...
Related Keywords
Burlington
,
Washington
,
United States
,
American
,
Harith Rajagopalan
,
Beth Brett
,
Elisa Davidson
,
American Gastroenterological Association
,
Society For Surgery Of The Alimentary Tract
,
Exchange Commission
,
Nasdaq
,
American Society For Gastrointestinal Endoscopy
,
While The Company
,
Corporate Communications
,
Company Rejuva
,
Stephen Jasper Gilmartin Group
,
Fractyl Health
,
Fractyl Health Inc
,
Fractyl Health Rejuva
,
Digestive Disease Week
,
Chief Executive Officer
,
Reduces Hepatic Triglycerides
,
Murine Model
,
About Fractyl
,
American Association
,
Liver Diseases
,
American Society
,
Gastrointestinal Endoscopy
,
Alimentary Tract
,
Private Securities Litigation Reform Act
,
Quarterly Report
,
Chief Financial Officer
,
comparemela.com © 2020. All Rights Reserved.